Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yarrow + moringa is an experimental herbal combination therapy being developed by Deraya University for the treatment of gingivitis. The formulation consists of nanoparticles derived from yarrow (*Achillea millefolium*) and moringa (*Moringa oleifera*) extracts, which are loaded into a bucco-adhesive film for localized delivery to the oral mucosa. This combination is designed to leverage the synergistic antibacterial and anti-inflammatory properties of both plants. Yarrow is traditionally known for its anti-inflammatory and astringent effects, while moringa provides potent antimicrobial activity against common oral pathogens. In clinical studies, this nanoparticle-loaded film is being evaluated for its ability to reduce dental plaque and gingival inflammation as a potential natural alternative to conventional treatments like chlorhexidine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yarrow + moringa (Deraya University).